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To study the decreasing responsiveness of the immune system during aging, influenza virus specific cellular immunity was
investigated in a cohort of healthy blood donors between 18 and 70 years of age. The percentage of influenza A virus specific
T cells was determined by flow cytometry and found not to change during aging. After stimulation with phorbol 12-myristate
13-acetate and ionomycin, an increase in the percentage of IFN- and IL-4 producing CD8 T cells was observed during
aging. In addition, the cytotoxic T lymphocyte (CTL) activity was investigated in two additional groups of five donors, 18–20
and 68–70 years of age. The lytic capacity of purified CD8 T cells, after in vitro stimulation of peripheral blood mononuclear
cells with influenza A virus, seemed lower in 68- to 70-year-old donors than in 18- to 20-year-old donors. Therefore we
conclude that the reduced CTL activity in the elderly is not the result of a lower frequency of virus-specific T cells, but moreINTRODUCTION
The elderly form a growing group at high risk for
complications related to infections with respiratory syn-
cytial virus (RSV) and influenza virus, resulting in high
morbidity and mortality rates (Barker and Mullooly, 1980;
Falsey et al., 1995; Falsey and Walsh, 2000; Gross et al.,
1988; Mlinaric-Galinovic et al., 1996). The more severe
clinical course of these virus infections in the elderly can
partially be attributed to a reduced responsiveness of the
immune system, also known as immunosenescence. Im-
munosenescence has been associated with reduced T
cell proliferative responses to antigens and mitogens,
reduced interleukin-2 production, increased interferon-
(IFN-) production, and reduced expression of the co-
stimulatory molecule CD28 on T cells (Globerson and
Effros, 2000; Miller, 1996; Pawelec et al., 1997; Wick and
Grubeck-Loebenstein, 1997a). In the elderly this phe-
nomenon may also underlie lower vaccine efficacy (de
Jong et al., 2000).
In addition to the induction of virus-specific antibodies,
the induction of cellular immune responses has been
shown to contribute to protective immunity against influ-
enza. In mouse models the protective effect of CD8
cytotoxic T lymphocytes (CTL) has been demonstrated
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100against homologous and heterologous subtypes of influ-
enza virus (Fu et al., 1999; Kuwano et al., 1990; Ulmer et
al., 1998; Yap et al., 1978). Also in humans protective
immunity was associated with the induction of CTL re-
sponses (Bender et al., 1992; McMichael et al., 1983).
Furthermore, the selective pressure of CTL-mediated im-
munity indicates a role for CTL in the control of influenza
virus replication in infected individuals (Boon et al.,
2002b; Voeten et al., 2000). It has been described that
CTL activity is reduced in the elderly both in vivo (Glober-
son and Effros, 2000) and in vitro (Mbawuike et al., 1993,
1997; Powers, 1993). Several steps determine the extent
of CTL activity after stimulation with antigen during in-
fection. These steps include the virus-specific CTL pre-
cursor frequency (CTLp) in the pool of memory cells, the
stimulation and subsequent expansion of virus-specific
cells, and the cytolytic effector function per cell. The
latter is still a matter of debate since some reports
describe a reduced expression of perforin and granzyme
in the elderly, while others describe no change in CTL
activity on a per cell basis (Globerson and Effros, 2000).
Currently no data are available on the frequency of virus-
specific CTL during aging. In the present study, the CTLp
frequency of influenza virus specific CTL was investi-
gated in a cohort of 87 donors of various ages, ranging
from 18 to 70 years. It was found that the number of
virus-specific CTL remained stable during aging. Thus
the reduced in vitro CTL activity of activated peripherallikely the result of impaired antigen-specific proliferation o
Key Words: aging; immunosenescence; flow cytometry;
Molewaterplein 50, 3015 GE Rotterdam, Netherlands. Fax: 010-4089485.
E-mail: rimmelzwaan@viro.fgg.eur.nl.
doi:10.1006/viro.2002.1491
0042-6822/02 $35.00lytic capacity of these cells. © 2002 Elsevier Science (USA)
ic T-lymphocyte; influenza virus.
blood mononuclear cells (PBMC) obtained from elderly
people cannot be explained by fluctuations in the quan-r lower
cytotox
tity of virus-specific CTL. Functional studies performed
with PBMC from a group of 18- to 20-year-old individuals
and a group of 68- to 70-year-old individuals indicated
that the observed reduction of CTL activity in vitro is
more likely the result of a reduced proliferation of T cells
upon activation or a reduced lytic capacity of the CTL.
RESULTS
Serology
The sera of all 87 donors were tested for the presence
of influenza A virus specific antibodies. Only one donor
had no hemagglutination inhibition (HI) titer against any
of the influenza viruses. The remaining 86 donors had
serum antibodies against influenza A virus (H1N1 or
H3N2), indicating that they had been infected with influ-
enza A virus.
Precursor frequency of influenza A virus specific T
cells
Of the 82 donors tested for the presence of influenza A
virus specific CD3 CD8 cells, 45 donors (55%) were
positive and had a higher percentage IFN- cells
within the CD3 CD8 fraction of the PBMC than the
cutoff value of 0.11% (dotted line, Fig. 1C). Comparing the
percentage of influenza A virus specific IFN- cells in
the CD3 CD8 population among donors of various
ages, no age-related differences were observed (aver-
age 0.23%, solid line, Fig. 1C, P 0.778). In addition to
CTLp frequency, the percentage of virus-specific cells in
the CD3 CD4 population was determined and found to
be lower than the frequency of virus-specific CD3 CD8
cells. In 33 (40%) of 85 donors tested for virus-specific
INF- CD3 CD4 cells the percentage IFN- cells in
the CD3 CD4 cells was higher than the cutoff value
(dotted line, Fig. 1D). The average percentage IFN-
cells in CD3 CD4 was 0.16% in these 33 donors, while
the overall average percentage of virus-specific cells in
the CD3 CD4 population was 0.07%. Again, no age-
related differences were found in the percentage of
IFN- CD3 CD4 cells (solid line, Fig. 1D, P  0.657).
Finally, the frequency of all influenza A virus specific
CD3 cells was determined in 79 donors, of whom 56
donors (71%) proved to be positive. The average percent-
age IFN- cells in the CD3 population in all donors
was 0.21%, ranging from 0.0 to 1.49%. The frequency of
virus-specific cells in the CD3 population also did not
differ significantly (P  0.628) between donors of differ-
ent ages (data not shown).
Percentage of IFN- and interleukin-4 producing T
cells after PMA (phorbol 12-myristate-13-acetate) and
ionomycin stimulation
The percentage IFN- cells within the CD3 CD8
population was found to increase during aging after
stimulation of PBMC with PMA/ionomycin (P  0.001,
closed symbol, Fig. 2A). A similar increase, although less
pronounced, was found in CD3 cells (P  0.001, open
symbol, Fig. 2A). The difference between percentage
IFN- cells in the CD3 CD8 population and in the
CD3 population increased gradually during aging. Also
the percentage interleukin-4 (IL-4) producing cells within
the CD3 CD8 compartment increased during aging
(P 0.003, Fig. 2B). Since the percentage of both IFN-
and IL-4 cells was determined in the CD8 T cell
fraction, the ratio between IFN- and IL-4 CD8 T
cells was calculated in cytokine-positive donors. The
ratio of IFN- vs IL-4 producing CD3 CD8 cells after
PMA/ionomycin stimulation increased during aging, al-
though this change was not statistically significant (P 
0.124, Fig. 2C).
FIG. 1. Precursor frequency of influenza A virus specific T cells in
fresh PBMC of donors of various ages. PBMC were stimulated ex vivo
with influenza A virus (H3N2, Resvir-9) as described under Materials
and Methods. A and B show intracellular IFN- staining in unstimulated
(A) and influenza A virus (Resvir-9) stimulated (B) CD3 cells. The
percentage IFN- cells in a large number of donors of various ages
is depicted within the CD3 CD8 cells (C, n  82) and CD3 CD4
cells (D, n 85). The cutoff value is represented by the dotted line (- - -)
and the correlation between percentage IFN- cells and age by the
solid line (—).
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Influenza virus specific CTL effector function in 18- to
20- and 68- to 70-year-old donors
Once it was concluded that the frequency of influenza
A virus specific CTL did not fluctuate during aging and
therefore as such did not contribute to a reduced CTL
activity of PBMC from the elderly, it was decided to
investigate the CTL activity of PBMC in greater detail.
Therefore PBMC of five donors between 18 and 20 years
and five donors between 68 and 70 years of age were
stimulated in vitro with influenza A virus.
Lymphoproliferative response of PBMC
First the PBMC obtained from the five 18- to 20- and
68- to 70-year-old donors were evaluated for signs of
immunosenescence. The T cell proliferative response
after stimulation with influenza antigen at different con-
centrations was significantly higher in 18- to 20-year-old
donors than in donors 68–70 years of age (avg. P 
0.025, Fig. 3A). This difference was not dependent on the
dose of antigen used for stimulation of the PBMC.
Phenotype of CD4 and CD8 T cells
The CD45RA, CD45RO, and CD28 expression was
determined in both CD4 and CD8 T cells. In the CD3
CD4 cells of 18- to 20-year-old donors the CD45RA and
CD45RO expression was evenly distributed (Fig. 3B),
while the majority of the CD3 CD8 cells expressed
CD45RA (Fig. 3D). In the 68- to 70-year-old donors both
the CD4 and the CD8 T cells mainly expressed
CD45RO (Figs. 3B and 3D). The number of CD4 and
CD8 T cells expressing CD28 was reduced in donors
68–70 years of age, but this reduction was more pro-
nounced in CD8 T cells (Figs. 3C and 3E).
CTL activity of influenza virus stimulated PBMC
Following in vitro stimulation of PBMC with influenza A
virus, the CTL effector cells were tested for their ability to
lyse influenza A virus infected autologous target cells. In
Fig. 4, the specific lysis was plotted against the CD8:
Target cell ratio for the 18- to 20-year-old (Fig. 4A) and the
68- to 70-year-old (Fig. 4B) donors, enabling us to deter-
mine the percentage of specific lysis at a given CD8:
Target cell ratio, which is a measure for both the lytic
activity of the effector cells and the number of virus-
specific cells present in the effector cell population. The
average percentage specific lysis at a CD8:Target cell
ratio of 10:1 was similar between both groups. The
slopes of the curves are an indication for the lytic ca-
pacity of the virus-specific effector cells. The lytic capac-
ity of the effector cells, calculated as the average corre-
lation coefficient, seemed lower in the group of 68- to
70-year-old donors, although the difference was not sta-
tistically significant (P  0.25, Fig. 4C).
DISCUSSION
In the present article it was shown that precursor
frequencies of influenza A virus specific T cells remain
stable during aging, indicating that the reduced CTL
activity of T cells after stimulation in vitro in the elderly is
not the result of a reduction in the numbers of virus-
specific cells during aging, but more likely the result of
impaired antigen-specific proliferation or lower lytic ca-
pacity of these cells.
The frequency of influenza virus specific T cells was
determined ex vivo in fresh PBMC of donors of various
ages. First, PBMC were infected with influenza A virus for
6 h, allowing the antigen-presenting cells (APC) to
present viral antigens in both HLA class I and HLA class
II molecules on the surface of the cell (Kuijpers et al.,
FIG. 2. Percentage IFN- and IL-4 positive T cells in PBMC after
stimulation with PMA/ionomycin. PBMC were stimulated ex vivo with
PMA/ionomycin for 6 h at 37°C, followed by intracellular IFN- and IL-4
staining, as described under Materials and Methods. (A) Percentage
IFN- cells within the CD3 CD8 cell population (F) and CD3 cell
population (E) in donors of various ages. A significant increase in the
percentage IFN- cells in the CD3 CD8 cells (—, P  0.001) and
in the CD3 cells (- - -, P  0.001) was observed during aging. (B)
Percentage of CD3 CD8 cells producing IL-4 in donors of various
ages. A significant increase (—, P  0.003) in the percentage IL-4
CD3 CD8 cells during aging was observed. (C) Ratio between IFN-
and IL-4 producing CD3 CD8 cells did not change during aging (—,
P  0.124).
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1992). In the PBMC population the APC are B cells and
monocytes, of which the latter can be efficiently infected
by influenza virus (Nichols et al., 2001). Previous studies
have shown that the APC within the influenza virus in-
fected PBMC can stimulate high numbers (2–4%) of vi-
rus-specific CD8 T cells (Boon et al., 2002a). The induc-
tion of apoptosis through the Fas-FasL pathway, as re-
cently described (Nichols et al., 2001), does not interfere
with our assay, since in vitro experiments with FasL-
specific monoclonal antibodies (MAb) confirmed that ap-
optosis of T cells is a random process (unpublished
observation).
The average frequency of influenza A virus specific
IFN- producing cells within the CD8 T cell population
remained stable during aging and was similar to previ-
ously reported precursor frequencies of EBV-, influenza A
virus-, or measles virus specific CD8 T cells (Boon et al.,
2002a; Crucian et al., 2001; Nanan et al., 2000). The
average percentage virus-specific CD8 T cells (0.23%)
is higher than the average percentage virus-specific
CD4 T cells. A difference in the regulation of T cell
memory between CD4 T cells and CD8 T cells could
be the basis of a lower influenza virus specific CD4 T
cell frequency (Homann et al., 2001). In our cohort a
decline in the percentage CD3 cells in PBMC during
aging was observed (P  0.022) which could conceal a
possible decline in the frequency of influenza A virus
specific CTL in PBMC. However, when the frequency of
FIG. 3. Characteristics of PBMC obtained from five 18- to 20-year-old and five 68- to 70-year-old donors. (A) [3H]thymidine incorporation after
stimulation of 1  105 PBMC with a twofold serial dilution of Influvac 97/98 (g HA per strain/ml), including a negative control (medium). The mean
counts per minute (cpm) of five donors are given and shown to differ significantly (*P  0.05) between 18- to 20- and 68- to 70-year-old donors at
different antigen concentrations. The data are representative of two independently repeated experiments. (B and D) CD45RA (naı¨ve T cells, black
symbols) and CD45RO (memory T cells, white symbols) expression on CD3 CD4 cells (B) and CD3 CD8 cells (D) in 18- to 20-year-old donors
(F, E) and 68- to 70-year-old donors (, ƒ). (C and E) CD28 expression on CD3 CD4 cells (C) and CD3 CD8 cells (E) in 18- to 20-year-old donors
() and 68- to 70-year-old donors ().
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virus-specific CTL was analysed as a frequency of virus-
specific CD8 cells of all PBMC, still no significant dif-
ference (P  0.841) in frequency of influenza A virus
specific cells was observed during aging. The finding
that numbers of influenza A virus specific T cells do not
change during aging, even after adjusting for number of
CD3 T cells in the PBMC population, conflicts with other
studies which describe a reduced IFN- production after
stimulation with influenza virus (Bernstein et al., 1998;
Castle, 2000; Mbawuike et al., 1997; Ouyang et al., 2000).
In these studies ELISA systems were used to measure
cytokine production in culture supernatant of PBMC
which had been stimulated in vitro for several days.
Results obtained after prolonged in vitro stimulation do
not account for differences in proliferation of lympho-
cytes between young and old donors (this article; Bern-
stein et al., 1998; Globerson and Effros, 2000). Using flow
cytometry, cytokines can be detected in activated T cells
after a short period of stimulation which makes it possi-
ble to quantify numbers of virus-specific cells without the
need of in vitro proliferation of these cells. It could be
anticipated that in light of recurrent infections with influ-
enza A virus throughout a lifetime the CTLp frequency
would increase during aging. Our studies indicate, how-
ever, that this is not the case and that CTLp frequencies
remain stable. This would imply that after recurrent in-
fections the number of memory CD8 T cells return to a
certain basic level.
When the IFN- production of PBMC upon a mitogenic
stimulation between young and older individuals was
compared, conflicting results have been obtained (Born
et al., 1995; Cakman et al., 1996; Fagiolo et al., 1993;
Karanfilov et al., 1999; Sakata-Kaneko et al., 2000; Yen et
al., 2000). Our results, using flow cytometry, show a
significant increase in the percentage IFN- CD8 T
cells and IFN- CD3 cells, which is in accordance
with previous studies (Bandres et al., 2000; Sakata-
Kaneko et al., 2000). The increase in the number of
IFN--producing T cells coincides with an increased CTL
memory pool in the elderly (this paper; Effros, 2001; Wick
and Grubeck-Loebenstein, 1997b). It has been reported
that after stimulation of memory T cells a large variety of
cytokines, including IL-4 and IFN-, are produced (Beck-
man et al., 1994). This could account for the increase in
percentage IL-4 and IFN- CD8 T cells after PMA/
ionomycin stimulation. When the frequencies of IFN-
producing cells after stimulation with PMA and influenza
A virus were compared, a significant correlation was
found (P  0.028). To rule out a possible effect of high
PMA responders on the frequency of IFN- producing
influenza A virus specific CD8 T cells, statistical anal-
ysis was performed excluding these high PMA respond-
ers (60% IFN- cells within CD8 T cells). Again no
statistical difference in the frequency of influenza virus
specific IFN- CD8 T cells was found during aging
(P  0.617), indicating that the high PMA responders in
the elderly did not mask a possible decline in the fre-
quency of influenza virus specific CTL during aging.
In addition to an increase in the number of IFN-
producing CD8 T cells the percentage IL-4 CD8 T
cells, after PMA/ionomycin stimulation, was also in-
creased during aging. This in contrast to a previous
study (Bandres et al., 2000) reporting no difference in the
number of IL-4 producing CD8 T cells during aging.
However with ELISA systems an increase in IL-4 produc-
tion in CD8 T cells of older donors was found (Yen et al.,
2000). The ratio IFN- to IL-4 producing CD8 T cells was
increased in older donors, suggesting a shift toward Th1
phenotype of CD8 T cells. In some studies a shift
FIG. 4. Reduced lytic activity of CD8 T cells after in vitro stimulation
PBMC with influenza A virus. PBMC from five donors between 18 and
20 years old and five donors between 68 and 70 years old were
stimulated with influenza A virus (Resvir-9). After eight days of culture,
the CD4 and CD16 cells were depleted and the remaining effector
cells tested for lytic capacity in a CTL assay against influenza A virus
infected or uninfected autologous target cells (BLCL) at the indicated
CD8:Target cell ratio. The figure shows the percentage lysis of infected
target cells minus uninfected target cells for five 18- to 20-year-old
donors (A) and five 68- to 70-year-old donors (B). The slopes of the
trendlines (specific lysis vs CD8:Target cell ratio) for the five donors
between 18 and 20 years of age (F) and five donors between 68 and 70
years of age (E) was plotted (C).
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toward a Th2 response during aging is described, al-
though these studies measured cytokine production in
supernatant of in vitro cultured PBMC as opposed to
activated CD8 T cells obtained ex vivo. A shift toward
Th1 phenotype was also reported after PMA/ionomycin
stimulation of purified CD4 T cells (Sakata-Kaneko et
al., 2000).
To further investigate the CTL immunity to influenza A
virus in the elderly, CTL activity of purified CD8 T cells
obtained from five 68- to 70-year-old individuals was
investigated and compared with that of five 18- to 20-
year-old individuals. Functional and phenotypic differ-
ences between the groups indicated immunosenes-
cence, a shift from naı¨ve to memory cell phenotype,
reduced CD28 expression, and lower proliferative capac-
ity (Effros, 2001). The lysis of virus-infected cells by virus-
specific CTL is dependent on several variables, including
the number of virus-specific cells in the effector cell
population and the lytic capacity of these cells. A mea-
sure of the latter can be deduced from the slope of the
logarithmic trendline of the plots shown in Fig. 4. Our
results suggest that the lytic capacity per cell is lower in
older donors than in young donors, which could be
explained by a reduced perforin or granzyme expression
(Rukavina et al., 1998). More studies in larger cohorts of
donors are required to further investigate the lytic capac-
ity of CTL during aging. At certain CD8:Target ratios (10:1)
essentially no difference in CTL activity was observed
between PBMC obtained from 68- to 70-year-old donors
and the PBMC obtained from 18- to 20-year-old individ-
uals. The addition of exogenous IL-2 in our experiments
may have compensated for the reduction in CTL activity
of in vitro expanded CTL observed without the addition of
IL-2 (Mbawuike et al., 1993, 1997; Powers, 1993). The
reduced CTL activity in the elderly observed without the
addition of IL-2 to PBMC cultures may indicate that the
proliferation of virus-specific CD8 T cells is reduced by
defects in CD4 T cells. Indeed, we and others have
shown that the proliferation of virus-specific CD4 T cells
is severely impaired in the elderly.
Collectively, we conclude that during aging the precur-
sor frequency of influenza A virus specific CTL does not
fluctuate. Apparently the pool of memory CTL is main-
tained and repeated exposure to the virus does not
increase this pool. The reported reduction of CTL activity
in the elderly is most likely caused by other defects in
CD8 T cells or other cells of the immune system.
MATERIALS AND METHODS
Human subjects
Blood samples of 10 ml were collected in heparin-
containing vacutainers (Becton–Dickinson, Plymouth,
U.K.) at the bloodbank in Rotterdam from 87 donors of
various ages ranging from 18 to 70 years (Table 1). Within
4 h after collection, the blood was diluted in PBS (1:1),
and the PBMC were isolated by gradient centrifugation
using Lymphoprep (Nycomed, Oslo, Norway), as recom-
mended by the manufacturer. The cells were washed
three times in PBS and left overnight at 37°C in RPMI
1640 (Life Technologies, Rockville, MD) supplemented
with 10% pooled human AB serum, streptomycin (100
U/ml), penicillin (100 g/ml), glutamine (2 mM), and
2-mercaptoethanol (2 M) (R10H). The plasma, 1:1 di-
luted in PBS, was collected and stored at 20°C. From
two groups of donors, aged 18–20 years (n  5) and
68–70 years (n  5), buffy coats were obtained from
which PBMC were isolated and cryopreserved as previ-
ously described (Boon et al., 2002a). Before collecting
blood, informed consent was obtained from each of the
blood donors.
Preparation of B lymphoblastoid cell lines (BLCL)
Autologous Epstein–Barr virus (EBV)-transformed
BLCL of each of the five young and five old donors was
established by culturing 1–5  106 PBMC in 1.0 ml
culture supernatant from the EBV-producing cell line
S594 in 24-well plates as previously described (Rimmel-
zwaan et al., 2000).
Influenza virus
Sucrose-gradient purified influenza A virus (H3N2)
Resvir-9, a reassortant between A/Puerto Rico/8/34
(H1N1) and A/Nanchang/933/95 (H3N2), containing the
hemagglutinin (HA), neuraminidase (NA), and nucleopro-
tein (NP) of A/Nanchang/933/95, was used for the infec-
tion of PBMC or BLCL. The infectious virus titer (1  109
TCID50) was determined in cell culture using Madin-
Darby canine kidney (MDCK) cells as indicator cells as
previously described (Rimmelzwaan et al., 1998). For
lymphocyte proliferation studies, Influvac 97/98 (kindly
provided by Solvay Pharmaceuticals BV, Weesp, Nether-
lands), a trivalent vaccine consisting of the influenza
virus glycoproteins HA and NA from A/Johannesburg/
82/95 (H1N1), A/Nanchang/933/95 (H3N2), and B/Harbin/
7/94, was used.
TABLE 1
Demographics of Study Participants
Age
group
Total
no. Female Male
18–25 10 5 (50%)a 2 (20%)a
26–35 12 7 (58%) 5 (42%)
36–45 14 8 (57%) 6 (43%)
46–55 22 8 (36%) 14 (64%)
56–65 23 7 (30%) 16 (70%)
66–70 6 1 (17%) 5 (83%)
Total 87 36 (41%) 48 (55%)
a The gender of three donors was unknown.
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Enumeration of influenza A virus specific T cells
PBMC were resuspended and washed twice in RPMI
1640 supplemented with 10% foetal calf serum (FCS),
streptomycin (100 U/ml), penicillin (100 g/ml), and glu-
tamine (2 mM) (R10F) to remove influenza virus specific
antibodies present in the human serum. Subsequently,
1 106 PBMC were infected for 1 h at 37°C with Resvir-9
at a multiplicity of infection (m.o.i.) of 3. Uninfected PBMC
were included as a control. After 1-h incubation at 37°C,
the PBMC were spun down, resuspended in R10H, and
divided over two wells in a 96-well round-bottom Costar
plate (Corning Inc., Corning, NY), with each well contain-
ing 3  105 PBMC in 150 l R10H. After a previously
determined optimal period of 5 h at 37°C, Golgistop
(Pharmingen, San Diego, CA) was added and left for a
subsequent 6 h at 37°C. Influenza virus specific T cells
were visualised by intracellular IFN- staining and flow
cytometry (see below).
Enumeration of IFN- and IL-4 producing T cells upon
nonspecific stimulation
PBMC, 2  105 cells per well, were stimulated with 50
ng/ml PMA (Sigma Chemical Co., St Louis, MO) and 500
ng/ml ionomycin (Sigma) for 6 h at 37°C in R10F. The
percentage IFN- and IL-4 cells were determined us-
ing an intracellular cytokine staining protocol and flow
cytometry (see below).
Intracellular cytokine staining and flow cytometry
analysis
After stimulation of PBMC with PMA/ionomycin or in-
fluenza A virus, the cells were transferred to a V-bottom-
shaped 96-well plate and subsequently stained, fixed,
and permeabilised with the Cytofix/Cytoperm kit (Pharm-
ingen) according to instructions provided by the manu-
facturer. Briefly, PBMC were washed once in PBS with
2.0% FCS (P2F) and incubated with a mix of anti-human
CD3-RPE-Cy5 (Dako, Glostrup, Denmark) and anti-hu-
man CD8-FITC (Dako) or anti-human CD3-RPE-Cy5 and
anti-human CD4-FITC (Dako) in 50 l P2F for 30 min at
4°C. Following two washing steps with P2F, the cells
were fixed with 100 l Cytofix buffer for 30 min at 4°C.
Next, the cells were washed twice in permeabilisation
buffer and subsequently incubated for 30 min at 4°C in
50 l permeabilisation buffer containing anti-human IFN-
-PE (Pharmingen) or anti-human IL-4-PE (Pharmingen).
After two washing steps with permeabilisation buffer, the
cells were resuspended in P2F, and the number of cyto-
kine-positive cells was determined using flow cytometry
(FACS scan, Becton–Dickinson). The percentage of cyto-
kine-positive cells within the CD4 or CD8 T cell frac-
tion was obtained from one well, while the percentage of
cytokine-positive cells within the CD3 T cells was cal-
culated from duplicate wells. Sporadically we were un-
able to determine the virus-specific precursor frequency.
After stimulation with influenza virus, the percentage
IFN- cells was determined within the CD3, CD4,
and CD8 T cell compartments (Figs. 1A and 1B), while
after mitogenic stimulation, both the percentage of
IFN- and the percentage IL-4 cells were determined
within CD8 T cell population and the percentage
INF- cells were determined within CD3 cells. Results
are given as the percentage cytokine-positive cells cal-
culated from the percentage after stimulation with either
influenza virus or mitogen minus unstimulated control
cells. The cutoff value was calculated from the average
percentage cytokine positive cells of the unstimulated
PBMC plus one time the standard deviation (SD).
Serology
Serum samples were tested for the presence of influ-
enza A virus specific antibodies in the HI test according
to standard methods (Masurel et al., 1981; Palmer et al.,
1975) using turkey erythrocytes and four hemagglutinat-
ing units of virus. The samples were tested against 10
influenza A virus (H3N2) vaccine strains from the intro-
duction of H3N2 (A/HongKong/1/68) until one of the most
recent H3N2 vaccine strain (A/Sydney/5/97) and for an-
tibodies against nine influenza A virus (H1N1) strains,
from the first isolate of H1N1 (A/Puerto Rico/8/34) until
the latest H1N1 vaccine component (A/New Caledonia/
20/99). Ferret sera raised against the test antigens were
used as positive controls.
Phenotypic analysis of PBMC
Cryopreserved PBMC, from the groups of 18- to 20-
year-old and 68- to 70-year-old donors (n 10) were ana-
lysed for memory and naı¨ve T cell phenotype and CD28
expression. Approximately 2  105 PBMC were resus-
pended in 50 l P2F and incubated for 30 min at 4°C with
different combinations of MAb. For the staining of
T lymphocytes MAb directed to human CD3 (Dako),
CD4 (Dako), CD8 (Dako), CD45RA-FITC (Pharmingen),
CD45RO-Cy-Chrome (Pharmingen), and CD28-RPE
(Pharmingen) were used. The cells were subsequently
washed once in P2F and analysed by flow cytometry.
Proliferative response of donor PBMC
To determine their proliferative capacity, PBMC (1 
105) of donors between 18 and 20 or 68 and 70 years of
age were transferred to a U-bottom-shaped 96-well plate
in 150 l R10H and stimulated with a twofold serial
dilution of Influvac 97/98, starting at 2.0 g/ml HA per
virus strain. A medium control was included to determine
nonspecific proliferation. After a 5-day incubation at
37°C, 0.5 Ci [3H]thymidine was added to each well and
subsequently incubated for 18 h at 37°C prior to harvest-
ing. Results were calculated from triplicate wells and
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given as the average counts per minute (cpm) of all
donors  the standard error of the mean (SEM).
Generation of influenza A virus specific CTL effector
cells from PBMC
To assess influenza A virus specific CTL activity in
vitro, PBMC were stimulated with Resvir-9 as previously
described (Boon et al., 2002a). Briefly, 5  106 PBMC
were infected with Resvir-9 at an m.o.i. of 3 for 1 h at
37°C in R10F. Following centrifugation, the PBMC were
resuspended in R10H and added to uninfected PBMC at
a ratio of 1:1. After 2 days at 37°C, rIL-2 (50 U/ml final
concentration) was added, and the cells were incubated
for another 6 days. Prior to the CTL assay CD4 cells
were depleted using M-450 Dynabeads (Dynal, Oslo,
Norway), followed by the depletion of NK cells with
anti-human CD16 MAb (Pharmingen) coupled to Pan
anti-mouse IgG beads (Dynal) according to manufactur-
er’s instructions. The remaining effector cell population
was used to assess the lytic ability of effector cells. The
depletion of CD4 and CD16 cells was validated on
every occasion and the percentage CD4 CD3 cells
and CD16 CD3 cells was determined by flow cytom-
etry. Contamination with these cell populations never
exceeded 2.0%. The percentage CD8 CD3 T cells in
the remaining effector cell population was determined to
calculate the CD8:Target (CD8:T) cell ratio used in the
cytotoxicity assay.
Cytotoxicity assay
Autologous BLCL were used as target cells and in-
fected with Resvir-9 at an m.o.i. of 1 for 1 h at 37°C, spun
down, and resuspended in R10F. After 16 h at 37°C,
influenza A virus infected BLCL and uninfected BLCL
were washed in serum-free medium and labeled for 1 h
at 37°C with 50 Ci Na2[
51Cr]O4 per 5  10
5 cells.
Following three washing steps with R10F, the target cells
were added to effector cells at different CD8:Target cell
ratios for 4 h at 37°C and the supernatant was subse-
quently harvested. The percentage specific lysis was
calculated with the following formula: ((experimental re-
lease  spontaneous release)/(maximal release 
spontaneous release))  100. The average percentage
specific lysis was calculated from a minimum of three
wells and given as the percentage lysis of virus-infected
autologous BLCL minus the percentage lysis of unin-
fected autologous BLCL. The slope of each plot was
calculated with the logarithmic trendline between CD8:
Target cell ratio and the percentage specific lysis.
Statistical analysis
The relationship between percentage cytokine posi-
tive cells and age was calculated with a two-tailed Pear-
son bivariate correlation assay. P values below 0.05 were
considered statistically significant. The statistical signif-
icance in lytic ability of effector cells and proliferation of
PBMC obtained from 18- to 20-year-old and 68- to 70-
year-old donors was determined with Student’s t test.
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